MMV 367
Alternative Names: GSK-701; MMV-1582367; MMV-367Latest Information Update: 25 Jan 2024
At a glance
- Originator Medicines for Malaria Venture
- Class Antimalarials
- Mechanism of Action Coenzyme A ligase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Malaria
Most Recent Events
- 30 Oct 2023 Medicines for Malaria Venture completes a phase Ib trial for Malaria in Australia (PO) (NCT05979207)
- 01 Aug 2023 Phase-I clinical trials in Malaria treatment (In volunteers) in Australia (PO) (NCT05979207)
- 05 Dec 2022 Medicines for Malaria Venture completes a phase I trial in Malaria (In volunteers) in United Kingdom (PO) (ISRCTN17423851)